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Abstract
Efficient and effective viral detection methodologies are a critical piece in the global
response to COVID-19, with PCR-based nasopharyngeal and oropharyngeal swab testing
serving as the current gold standard. With over 100 million confirmed cases globally, the
supply chains supporting these PCR testing efforts are under a tremendous amount of
stress, driving the need for innovative and accurate diagnostic solutions. Herein, the utility of
a direct-to-PCR method of SARS-CoV-2 detection grounded in mechanical homogenization
is examined for reducing resources needed for testing while maintaining a comparable sen-
sitivity to the current gold standard workflow of nasopharyngeal and oropharyngeal swab
testing. In a head-to-head comparison of 30 patient samples, this initial clinical validation
study of the proposed homogenization-based workflow demonstrated significant agreeabil-
ity with the current extraction-based method utilized while cutting the total resources needed
in half.
Introduction
The COVID-19 global pandemic caused by SARS-CoV-2 has dominated the clinical and
research landscapes since its designation by the World Health Organization in March of 2020
[1]. Stretching to all corners of the globe, SARS-CoV-2 has been detected in most communities
causing activation of public health efforts geared towards disease surveillance and prevention
practices [2–4]. Efficient and effective SARS-CoV-2 detection methods are the cornerstone of
these public health efforts [2–4]. Following the common detection method of many other
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positive-sense RNA respiratory viruses, reverse transcriptase polymerase chain reaction
(RT-PCR) testing quickly emerged as the global standard for accurate SARS-CoV-2 detection
from patient samples [3, 4]. Due to their high sensitivity for viral detection, nasopharyngeal
and oropharyngeal swabs are widely used sample types obtained from patients for the purpose
of RT-PCR based COVID-19 testing [3].
In the traditional model of RT-PCR viral testing, swab samples are collected from the
patient, stored in viral transport media at the collection site, and sent to the laboratory for pro-
cessing via molecular techniques including viral RNA extraction and purification utilizing a
series of chemical reagents followed by RT-PCR for viral detection [3, 5, 6]. While proven
effective, this traditional model requires a significant quantity of consumable plastics and
chemical reagents to complete, particularly in the extraction and purification steps that include
multiple rounds of digestions and different buffer washes [7]. As the COVID-19 pandemic
spread, the international supply of the common reagents and plastics used in viral genetic
extractions and RT-PCR testing became increasingly stressed reducing access to adequate test-
ing and driving up prices to health systems and patients [7].
With the demand for testing increasing secondary to viral spread throughout communities,
the need for cost effective and accurate diagnostic capabilities drove the innovation of novel
viral detection methodologies [3, 4, 6, 7]. One way to reduce cost and increase access to SARS--
CoV-2 testing is to reduce the resources needed for detection, without reducing the sensitivity
of the testing assays. Technologies such as isothermal PCR reactions, direct-to-PCR testing
procedures, and colorimetric PCR-based viral detection methodologies have all been proposed
to address the issue of access to accurate testing in a resource challenged setting [8–10].
Herein, the authors are utilizing a mechanical homogenization based direct-to-PCR viral
detection method for SARS-CoV-2 detection from nasopharyngeal and oropharyngeal swabs
to screen for both symptomatic and asymptomatic COVID-19 in Blantyre, Malawi. This
homogenization based direct-to-PCR viral detection workflow was previously examined utiliz-
ing in vitro simulated nasopharyngeal swab samples spiked with clinically significant levels of
human coronavirus 229E (HCoV-229E) for proof of concept testing [10]. In the initial study,
the laboratory simulated samples processed using this novel methodology revealed a limit of
detection of 1.2x103 viral copies/mL with 96.30% sensitivity when detecting HCoV-229E [10].
While this technology has been reported as a proof of concept, in vitro observation, this
brief manuscript examines the clinical feasibility and efficiency of this methodology [10]. In a
head-to-head comparison of the direct-to-PCR testing and the traditional extraction-based
PCR testing methods, asymptomatic and mild to moderately symptomatic patients were
screened with both methods for SARS-CoV-2 detection.
Materials and methods
Sample collection
The upper respiratory tract samples used for this method validation study were obtained
through the University of Malawi College of Medicine (Blantyre, Malawi). All samples were
obtained with informed patient consent following the COVID-HCWEXPO protocols in IRB
contract P.05/20/3053 approved by the Institutional Review Board of the University of Malawi
College of Medicine (Blantyre, Malawi). Informed consent was obtained from all subjects
involved in the study prior to participation. The study recruited participants over the age of 18
and consent was obtained via written consent by each participant and witnessed by the
researcher collecting the sample.
Upper respiratory tract samples were obtained from a prospective cohort study to compare
the risk of SARS-CoV-2 infection and exposure in healthcare workers compared to
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community members in Blantyre, Malawi between June and August 2020 (manuscript in prep-
aration). 15 SARS-CoV-2 PCR positive and 15 SARS-CoV-2 PCR negative were randomly
selected from the cohort of 300 adult participants. (Table 1). Patients presenting to the hospital
with suspected severe COVID-19 in respiratory distress were excluded from this study.
At the time of sample collection, each patient provided two swab specimens, one nasopha-
ryngeal swab and one oropharyngeal swab which were immediately stored in a single tube
containing viral transport media to await further processing [5, 11]. Following sample collec-
tion, samples were stored at 4 C for up to 24 hr, if the sample was not going to be processed
within the next 24 hr it was stored at -80 C until processing could occur.
Extraction-based sample preparation
One mL of viral transport media was taken from the tube containing the nasopharyngeal and
oropharyngeal swabs at room temperature and utilized in the Omega Bio-Tek Mag-Bind Viral
DNA/RNA Kit in accordance with manufactures guidelines (Omega Bio-Tek, Cat. No.
M6246). Final product of purified viral RNA was held on ice in preparation for PCR testing.
Table 1. RT-qPCR results following the extraction-based and homogenization-based protocols represented as Ct
values for each patient sample.
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Homogenization-based sample preparation
One mL of viral transport media was transferred from the original sample collection tube to a
2 mL screw cap tube (Omni International Inc, Cat. No. 19–647) and sealed. Sample tubes were
then loaded into the Omni Bead Ruptor Elite (Cat. No. 19–647) for processing [10]. The sam-
ples were run at 4.2 m/s for 30 s, removed from the device, and allowed to sit for 60s following
processing to allow for any forth in the tubes to settle [10].
RT-qPCR detection of SARS-CoV-2
Following sample processing with either the extraction-based or homogenization-based meth-
ods, CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel (Cat.
No. 2019-nCoVEUA-01 1000 reactions) was used for detection of SARS-CoV-2. Briefly, 5μL
of purified RNA or lysate, respectively was transferred into 15 μL reactions of Quantabio
qScript XLT One-Step RT-qPCR ToughMix comprising of 3.5μL Nuclease-free Water, 1.5μL
Combined Primer/Probe Mix, and 10μL qScript XLT One-Step RT-qPCR ToughMix (2X).
The RT-qPCR reaction was premixed following vendor instructions and then loaded into the
QuantiStudio 7 Flex Real Time PCR System (ThermoFisher Scientific, Cat. No. 4485698) and
run with the vendor recommended temperature and cycle timing for a total of 45 amplification
cycles. Cycle threshold (Ct) values were recorded and any sample with a Ct value less than or
equal to 40 was labeled as positive for COVID-19 detection based on the US CDC recom-
mended analysis of COVID-19 probe-based RT-qPCR results (Fig 1 and Table 1) [11].
Fig 1. RT-qPCR results for SARS-CoV-2 detection utilizing the extraction-based or homogenization-based methods as
demonstrated by paired Ct values. The blue bars depict Ct values following the extraction-based method and gold bars represent Ct
values following the homogenization-based method.
https://doi.org/10.1371/journal.pone.0256316.g001
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Statistical comparison of extraction and homogenization methodologies
When comparing the extraction and homogenization-based sample preparation techniques
described above, the final Ct values resulting from each method were paired under the original
patient identification number for direct comparison. For the purpose of statistical analysis of
the final results, negative samples where no amplification was detected in the presence of con-
firmed internal controls, were assigned a Ct value of 45.0. The positive predictive value (PPV)
and negative predictive value (NPV) for the homogenization-based workflow were calculated
using the extraction-based workflow as the gold standard method to compare against
(Table 2). Additionally, the two resultant Ct values linked to the same patient from each testing
method were plotted against each other for correlative visualization and a standard best fit line
was produced to evaluate the R2 value (Fig 2).
Results
When directly comparing the capabilities of homogenization-based, direct-to-PCR workflow
to traditional, extraction-based methodology for SARS-CoV-2 detection off nasopharyngeal
and oropharyngeal swabs there was an overall 80% agreeability between both methods. A
strong positive correlation was observed when plotting Ct values produced utilizing both
examined methods linked to the same patient sample as demonstrated with an R2 of 0.763
(Fig 2). Except for one patient, all paired positive samples show a Ct value following homoge-
nization-based testing to be greater than the extraction-based testing for the same patient
(Fig 1 and Table 2). However, there were noted to be 6 positive samples that demonstrated dis-
agreement following processing under both methodologies, where a sample was Ct positive for
Table 2. RT-qPCR results displayed as Ct values for patients with positive SARS-CoV-2 detection utilizing either the extraction-based or homogenization-based
workflows.
Sample Extraction Ct Value Homogenization Ct Value Positive Predictive Value Negative Predictive Value


















Positive predictive values and negative predictive values shown are calculated with the extraction-based workflow serving as the gold standard for reference. The PPV
and NPV were also calculated following the proposed Ct cut off 37.0 for positives as well as the current 40.0 standard cut off for positive designation.
https://doi.org/10.1371/journal.pone.0256316.t002
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SARS-CoV-2 utilizing one method and not the other (Table 2). There was an equal distribu-
tion of disagreement between both testing methodologies with 3 of 30 patients testing positive
for COVID-19 with extraction-based testing (patients 13, 14, and 15) and negative with the
homogenization-based testing, and then the reverse with 3 of 30 patients testing positive for
COVID-19 with homogenization-based testing (patients 16, 19, and 29) and negative with
extraction-based testing (Table 2). These disagreements in SARS-CoV-2 detection were
observed in samples which had results of Ct values greater than 37.08, indicating a low viral
load (Tables 1 and 2). When comparing Ct values below 37.08, there was a 100% agreement
for detection of SARS-CoV-2 utilizing both methodologies (Table 2).
Discussion
In this clinical validation study, we utilized 30 paired nasopharyngeal and oropharyngeal swab
samples participants in a prospective cohort study to assess the occupational risk of SARS--
CoV-2 infection or exposure in Blantyre, Malawi to examine the efficacy of a direct-to-PCR,
homogenization-based workflow when compared to the gold standard extraction-based work-
flow for detection of SARS-CoV-2. 80% agreeability between all samples following processing
was noted, with a positive direct correlation between the resultant Ct values produced when
processing each sample with both methods. An R2 of 0.763 and positive predictive value of
80% demonstrate a moderate level of acceptability for implementing the proposed direct-to-
PCR method into clinical practice. Additionally, when moving the negative detection cut off
Ct value from 40.0 to 37.0 the improvement of both the positive predictive value and negative
Fig 2. RT-qPCR results of SARS-CoV-2 plotting extraction-based Ct values versus homogenization-based Ct values for
correlation evaluation. The best fit line and R2 value displayed demonstrate the positive relationship between both testing
methodologies.
https://doi.org/10.1371/journal.pone.0256316.g002
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predictive value to 100% and agreement of 100% between both methodologies warrants fur-
ther investigation while strengthening the argument for clinical implementation.
Throughout the progression of the COVID-19 global pandemic, the need for efficient and
effective diagnostic testing has proven paramount to the global response, with PCR based viral
detection off swabs serving as the current gold standard for testing [2–4]. However, the tradi-
tional extraction-based methodology detailed in this manuscript requires many chemical
reagents to complete and has become financially burdensome secondary to strain placed on
the global supply chains for many of these reagents and consumable plastics. The increase in
demand for the supplies needed to complete the traditional extraction-based method coupled
with the limited global supply for the reagents created a scenario where many wealthy coun-
tries and communities were able to purchase all of the supplies needed for testing, leaving
resource challenged settings struggling to ensure availability of timely and accurate viral detec-
tion methods.
In addition to the high cost associated with the accurate extraction-based workflow, the
total run time for each sample to be processed in this method can take up to 3 hours from
extraction to PCR results when using a fully automated workflow. When receiving thousands
of samples per day, a backlog can easily be created utilizing the extraction-based method caus-
ing delays in relaying critical positive or negative results to patients and local health officials.
Developing approaches to reduce the total time per test while maintaining accuracy also
emerged as an area of needed innovation in response to the COVID-19 pandemic.
To address these limitations in viral testing many approaches have been proposed ranging
from point of care, lateral flow antigen tests to rapid PCR tests that offer solutions on either
time or cost associated with testing [6–8]. While many of the proposed technologies for
increasing testing either reduce time or reduce required reagents, they often do not achieve
both while maintaining diagnostic accuracy similar to the current extraction-based PCR work-
flow [6, 7]. Herein, the validation of the proposed direct-to-PCR, homogenization-based meth-
odology offers a solution through reducing the time and reagents needed to process each
sample while maintaining an acceptable level of accuracy when compared to the extraction-
based method.
Of note, the demonstrated agreeability between the direct-to-PCR and traditional methods
displayed a pattern of all except for one of the SARS-CoV-2 positive samples had a lower Ct
value following the extraction protocol versus the homogenization protocol. This is represen-
tative of the PCR inhibitors present in the lysate following homogenization that are not
removed due to the lack of chemical purification steps when compared to the extraction proto-
cols. Given the presence of inhibitors, it is expected that the Ct values are greater than the puri-
fied samples from kit-based extractions. However, the high agreeability in detecting
SARS-CoV-2 between the methods demonstrates that these inhibitors remaining in the lysate
transferred to the RT-qPCR in the homogenization method do not prohibit adequate RNA
amplification for detection. This pattern confirmed with a strong R2 value when plotting Ct
values from both methods against each other supports the reliability of the direct-to-PCR
workflow when dealing with the variability of viral loads in a clinical sample.
While we acknowledge that this initial clinical validation study demonstrated inconsistent
detection when the Ct values were greater than 37, the 100% positive predictive value and
100% negative predictive value at Ct values less than 37 qualifies this methodology for further
large-scale evaluations (Table 2). It has been documented that between commercially available
kits there is decreasing agreement on SARS-CoV-2 detection as Ct values grow past 36 [12–
14]. The authors acknowledge that this manuscript has its limitations in statistical robustness
and the limited data it provides, such as the lack of technical replicates or viral load quantifica-
tions. However, we felt it was prudent to disseminate the limited information we have
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developed around this novel process for viral detection in an effort to assist in the current
international need for COVID-19 testing innovation and improvement. It is our hope that this
efficient and cost-effective measure for COVID-19 PCR based testing can work to fill the void
in testing in many areas of the world.
Using the small mechanical footprint of a bench top homogenizer and a standard thermo-
cycler, and without the need of a multitude of chemical reagents, the direct-to-PCR workflow
can be set up almost anywhere. The ease of system configuration and simple operational steps
needed to complete this workflow support the adaptability of this novel method to be imple-
mented in any area, including resource challenged settings without the funds or laboratory
spaces to support fully automated extraction based viral testing systems. It is critical that we as
a global community continue to commit to the development of testing strategies to assist in
COVID-19 public health efforts in all areas of the world if we are going to implement success-
ful pandemic mitigation efforts.
Given the high levels of agreeability between the observed workflows, in conjunction with
the significant reduction in cost and processing time by utilizing a 30 second mechanical
homogenization step versus an hour-long reagent heavy extraction procedure, this direct-to-
PCR methodology has potential to be further incorporation into global COVID-19 detection
strategies. Herein, we believe our novel direct-to-PCR workflow is a potential solution to
increase access to efficient SARS-CoV-2 detection in resource challenged areas.
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